ClinicalTrials.gg
RecruitingNCT06735651Updated Sep 2, 2026

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

An interventional study of Wild Blueberry and Placebo in Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Female and Adult, sponsored by Georgia State University. Recruiting at 1 site in United States. Open to female participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Georgia State University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Sep 2024; still recruiting 2 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 65 Years
Sex
Female
01

Study summary

The goal of this clinical trial is to determine the effectiveness of using a freeze-dried wild blueberry powder on cardiometabolic health, cognitive function, and gut microbiota composition in adult women with prediabetes.

Read the detailed description

In the U.S., 35.3 million adults have type 2 diabetes mellitus (T2DM) and 96 million have prediabetes. Eight out of 10 people with T2DM die from cardiovascular disease. People with T2DM also have a 50% higher risk of developing dementia compared to healthy counterparts. Further, studies show that gut microbes play a major role in the development of T2DM. Prevention and treatment of T2DM focus on lifestyle changes including dietary modifications such as increased consumption of deep-colored fruits like berries. Blueberries are rich in fiber and phytochemicals and have several health benefits. We and others have shown that blueberry intake improves heart health in healthy men, hypertensive postmenopausal women, and men and women with metabolic syndrome. Yet, a comprehensive study in women with prediabetes that measures changes in cognitive performance and the underlying heart and gut health has not been conducted to date. Thus, the overall objective of this study is to investigate and bring forth evidence that wild blueberries improve gut, cardiometabolic, and cognitive function in women with prediabetes.

Therefore, this pilot six-week randomized, placebo-controlled parallel-arm clinical trial aims to investigate whether daily consumption of 22 g of freeze-dried wild blueberry powder improves gut, cardiometabolic, and cognitive function in women with prediabetes. Investigators hypothesize that daily consumption of wild blueberries will improve cardiometabolic parameters, gut dysbiosis, and cognitive impairments in our study population. To test these hypotheses, the following specific aims are proposed. To investigate whether daily consumption of 22 g of freeze-dried wild blueberry powder:

  • Reduces levels of fasting blood glucose (FBG), insulin, and HOMA-IR (homeostatic model assessment of insulin resistance) and improves lipid profile in women with prediabetes.
  • Reduces blood pressure and improves endothelial function in women with prediabetes.
  • Improves cognitive function (verbal memory and executive functions [inhibition, working memory, cognitive flexibility]) in women with prediabetes.
  • Favorably modulates gut microbiota composition in women with prediabetes.
  • Improves serum markers of oxidative stress and inflammation in women with prediabetes.

Additionally, whether changes in the gut microbiota are associated with changes in cardiometabolic and cognitive function outcomes and whether changes in cardiometabolic outcomes are associated with changes in cognitive function parameters will be explored.

02

Conditions studied

  • Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
  • Female
  • Adult
  • Endothelial Function (Reactive Hyperemia)
  • Arterial Stiffness
  • Cognition
  • Oxidative Stress
  • Gut Microbiota
  • Overweight
  • Inflammation
  • Microvascular Function
  • Body Composition

Keywords

  • Blueberries
  • Prediabetes
  • Insulin Resistance
  • Functional foods
  • Dietary intervention
  • Endothelial function
  • Vascular function
  • Cardiovascular health
  • Metabolic health
  • Gut microbiota
  • Cognitive function
  • Type II diabetes
  • Microvascular Function
  • Wild Blueberries
03

In context

Prediabetic State

918 studies on the registry are indexed under Prediabetic State; 232 are open to participants now.

This study's planned enrollment of 30 is below the median of 62 across 762 interventional studies indexed under Prediabetic State.

Browse Prediabetic State studies →

Lead sponsor

Georgia State University is the lead sponsor of 56 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 20-65 years old
  • Prediabetes (fasting blood glucose 100-125 mg/dL and/or percentage between 5.7-6.4)
  • between 25-30 kg/m\^2

Exclusion criteria

Exclusion Criteria:

  • Allergies to berries
  • Use of insulin, antidiabetic, antibiotics, and anti-inflammatory drugs
  • Active cancer, gastrointestinal, renal, thyroid, stage 1 \& 2 hypertension and other cardiovascular diseases, neurological diseases, or severe head injury
  • Smoking
  • Consumes greater than 2 alcoholic beverages per day
  • Consumes antioxidant, probiotic, and prebiotic supplements
  • Pregnant or Lactating
  • Actively participating in a weight loss program
  • Currently taking berry supplements or recently participated in another study taking berry supplements
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Wild Blueberry

    22 g of freeze-dried wild blueberry freeze-dried powder per day

    Dietary Supplement: Wild Blueberry

  • Placebo comparator
    Placebo

    22 g of freeze-dried macronutrient-matched placebo powder per day

    Dietary Supplement: Placebo

Interventions

  • Dietary supplementWild Blueberry

    Daily consumption of 22 g of freeze-dried wild blueberry freeze-dried powder for 6 weeks

  • Dietary supplementPlacebo

    Daily consumption of 22 g of freeze-dried macronutrient-matched placebo powder for 6 weeks

06

What researchers measure

Primary outcomes

  1. Blood Glucose

    Measurement of fasting blood glucose

    Time frame: Baseline and 6 weeks

  2. Ambulatory Blood Pressure

    Assessment of whole-day ambulatory blood pressure during daytime and nighttime periods.

    Time frame: Baseline and 6 weeks

Secondary outcomes

  1. Fasting Insulin

    Time frame: Baseline and 6 weeks

  2. Homeostasis model assessment-insulin resistance (HOMA-R)

    Calculated as fasting insulin (mU/mL) x fasting glucose (mg/dL)/405

    Time frame: Baseline and 6 weeks

  3. Blood Lipid Profile

    Measurement of blood lipid profile

    Time frame: Baseline and 6 weeks

  4. Gut Microbiota Composition

    Analysis of stool sample for determination of absolute levels of bacteria and relative species composition

    Time frame: Baseline and 6 weeks

  5. Global Cognitive Ability

    Measured using NIH Toolbox Picture Vocabulary test and Oral Reading Recognition

    Time frame: Screening

  6. Performance Validity

    Assessed using Rey 15

    Time frame: Baseline and 6 weeks

  7. Verbal Memory & Recognition

    Measured using Rey Auditory Verbal Learning Test with appropriate alternate forms

    Time frame: Baseline and 6 weeks

  8. Cognitive Inhibition

    Measured using Delis-Kaplan Executive Function System Color Word Interference, and NIH Toolbox Flanker Inhibitory Control and Attention

    Time frame: Baseline and 6 weeks

  9. Cognitive Flexibility

    Assessed using Delis-Kaplan Executive Function System Trails and Verbal Fluency Switching

    Time frame: Baseline and 6 weeks

  10. Working Memory

    Measured using Digit Span and NIH Toolbox List Sorting

    Time frame: Baseline and 6 weeks

  11. Processing Speed

    Measured using NIH Toolbox Pattern Comparison and Oral Symbol Digit tests

    Time frame: Baseline and 6 weeks

  12. Associative Memory

    Measured using NIH Toolbox Face Name Associative Memory Exam and Face Name Associative Memory Exam Delay tests

    Time frame: Baseline and 6 months

  13. Attention

    Assessed using Wechsler Adult Intelligence Scale - IV and Rey Auditory Verbal Learning Test Trial 1.

    Time frame: Baseline and 6 weeks

  14. Problem-Solving

    Assessed using NIH Toolbox Visual Reasoning Test

    Time frame: Baseline and 6 weeks

Other outcomes

  1. Reactive Hyperemia Index

    Assessment of endothelial function in response to increased shear stress using EndoPAT2000

    Time frame: Baseline and 6 weeks

  2. Pulse Wave Velocity

    Arterial Stiffness will be assessed by pulse wave velocity using SphygmCor

    Time frame: Baseline and 6 weeks

  3. Percent Maximal Microvascular Blood Flow

    Micro-vessel blood flow in response to local heating stimulus will be assessed using a Laser Doppler

    Time frame: Baseline and 6 weeks

  4. Circulating Markers of Inflammation and Oxidative Stress

    Measurement of concentrations of circulating markers of inflammation such as CRP and oxidative stress such as TBARS in blood plasma and serum samples.

    Time frame: Baseline and 6 weeks

  5. Urinary Polyphenolic Metabolites

    24-hour urine collection samples will be assessed for polyphenol metabolites

    Time frame: Baseline and 6 weeks

  6. Body Fat

    DEXA will be used to assess body fat.

    Time frame: Baseline and 6 weeks

07

Study locations

1 of 1 sites recruiting
  • Georgia State University
    Atlanta, Georgia 30303, United States
    Recruiting
    • Rafaela G Feresin, PhD · Contactberries@gsu.edu · 404-413-1233
    • Rafaela G Feresin, PhD · Principal investigator
    • Andrew Gerwitz, PhD · Sub investigator
    • Tricia Z King, PhD · Sub investigator
    • Brett J Wong, PhD · Sub investigator
    • Elizabeth L Tighe, PhD · Sub investigator
08

References and documents

Publications

  • Stote KS, Wilson MM, Hallenbeck D, Thomas K, Rourke JM, Sweeney MI, Gottschall-Pass KT, Gosmanov AR. Effect of Blueberry Consumption on Cardiometabolic Health Parameters in Men with Type 2 Diabetes: An 8-Week, Double-Blind, Randomized, Placebo-Controlled Trial. Curr Dev Nutr. 2020 Mar 9;4(4):nzaa030. doi: 10.1093/cdn/nzaa030. eCollection 2020 Apr. PubMed 32337475 ↗
  • Miller MG, Hamilton DA, Joseph JA, Shukitt-Hale B. Dietary blueberry improves cognition among older adults in a randomized, double-blind, placebo-controlled trial. Eur J Nutr. 2018 Apr;57(3):1169-1180. doi: 10.1007/s00394-017-1400-8. Epub 2017 Mar 10. PubMed 28283823 ↗
  • Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018 Oct;14(10):591-604. doi: 10.1038/s41574-018-0048-7. PubMed 30022099 ↗
  • Rawshani A, Rawshani A, Franzen S, Eliasson B, Svensson AM, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbjornsdottir S. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. N Engl J Med. 2017 Apr 13;376(15):1407-1418. doi: 10.1056/NEJMoa1608664. PubMed 28402770 ↗
  • Krikorian R, Skelton MR, Summer SS, Shidler MD, Sullivan PG. Blueberry Supplementation in Midlife for Dementia Risk Reduction. Nutrients. 2022 Apr 13;14(8):1619. doi: 10.3390/nu14081619. PubMed 35458181 ↗
  • Johnson SA, Figueroa A, Navaei N, Wong A, Kalfon R, Ormsbee LT, Feresin RG, Elam ML, Hooshmand S, Payton ME, Arjmandi BH. Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: a randomized, double-blind, placebo-controlled clinical trial. J Acad Nutr Diet. 2015 Mar;115(3):369-377. doi: 10.1016/j.jand.2014.11.001. Epub 2015 Jan 8. PubMed 25578927 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06735651
Lead sponsor
Georgia State University
Collaborators
Wild Blueberry Association of North America
Responsible party
Rafaela G. Feresin (Associate Professor, Georgia State University) — Principal investigator
First posted
Dec 16, 2024
Start date
Sep 20, 2024
Primary completion
Jun 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Sep 2, 2026

Study contacts

Rafaela G Feresin, PhD
Contact
berries@gsu.edu
404-413-1233
Rafaela G Feresin, PhD
principal investigator · Georgia State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion